XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Common Stock
Platinum Stockholder
Common Stock Contingent Consideration
Common Stock Contingent Consideration
Platinum Stockholder
Additional Paid-in Capital
Additional Paid-in Capital
Platinum Stockholder
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2018 $ 288,590   $ 16   $ 73,150   $ 327,642   $ (106,397)   $ (5,821)
Beginning Balance (Accounting Standards Update 2014-09) at Dec. 31, 2018   $ (257)               $ (257)  
Beginning Balance (in shares) at Dec. 31, 2018     156,057                
Net income (loss) 17,076               17,076    
Adjustment to equity infusion from Gores (7,001)           (7,001)        
Adjustment to tax receivable agreement liability 2,940           2,940        
Stock issued in exchange for business acquisitions         (18,288)   18,288        
Stock issued in exchange for business acquisitions (in shares)     2,500                
Vesting of restricted stock units ("RSUs") (in shares)     593                
Payment of employee tax withholding related to RSUs vesting (4,990)           (4,990)        
Stock-based compensation 10,012           10,012        
Other comprehensive income (loss), net of tax 3,244                   3,244
Ending Balance at Dec. 31, 2019 309,614   $ 16   54,862   346,891   (89,578)   (2,577)
Ending Balance (Accounting Standards Update 2016-13) at Dec. 31, 2019   $ (694)               $ (694)  
Ending Balance (in shares) at Dec. 31, 2019     159,150                
Net income (loss) (4,578)               (4,578)    
Stock issued in exchange for business acquisitions           $ (18,287)   $ 18,287      
Stock issued in exchange for business acquisitions (in shares)       2,500              
Vesting of restricted stock units ("RSUs") (in shares)     619                
Payment of employee tax withholding related to RSUs vesting (4,147)           (4,147)        
Stock-based compensation 12,589           12,589        
Other comprehensive income (loss), net of tax 2,788                   2,788
Ending Balance at Dec. 31, 2020 315,572   $ 16   36,575   373,620   (94,850)   211
Ending Balance (in shares) at Dec. 31, 2020     162,269                
Net income (loss) 41,449               41,449    
Share repurchase and retirement (100,000)           (71,985)   (28,015)    
Share repurchase and retirement (in shares)     (6,849)                
Vesting of restricted stock units ("RSUs") (in shares)     647                
Exercise of stock options 155           155        
Exercise of stock options (in shares)     12                
Payment of employee tax withholding related to RSUs vesting (5,691)           (5,691)        
Stock-based compensation 13,784           13,784        
Other comprehensive income (loss), net of tax (5,305)                   (5,305)
Ending Balance at Dec. 31, 2021 $ 259,964   $ 16   $ 36,575   $ 309,883   $ (81,416)   $ (5,094)
Ending Balance (in shares) at Dec. 31, 2021     156,079